Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker PASG
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | Weston Nichols 10% owner | PASG Passage Bio, Inc. | Buy | 50,055 | $4.12 | $206.2K Buy | Form 4 ↗ |
| Jan 8, 2026 | Kathleen Borthwick CFO | PASG Passage Bio, Inc. | Sale | 2,062 | $18.44 | $38.0K Sale | Form 4 ↗ |
| Jan 8, 2026 | William Chou PRESIDENT AND CEO, Director | PASG Passage Bio, Inc. | Sale | 4,076 | $18.44 | $75.2K Sale | Form 4 ↗ |
| Sep 15, 2025 | Weston Nichols 10% owner | PASG Passage Bio, Inc. | Buy | 11,900 | $6.99 | $83.2K Buy | Form 4 ↗ |
| Sep 12, 2025 | Weston Nichols 10% owner | PASG Passage Bio, Inc. | Buy | 19,783 | $6.99 | $138.3K Buy | Form 4 ↗ |
| Sep 11, 2025 | Weston Nichols 10% owner | PASG Passage Bio, Inc. | Buy | 325 | $6.96 | $2,262 Buy | Form 4 ↗ |
| Jul 24, 2025 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 66,423 | $5.71 | $379.3K Buy | Form 4 ↗ |
| Jul 23, 2025 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 49,302 | $5.74 | $283.0K Buy | Form 4 ↗ |
| Jul 22, 2025 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 13,123 | $5.44 | $71.4K Buy | Form 4 ↗ |
| Jun 26, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 213,257 | $0.33 | $70.4K Sale | Form 4 ↗ |
| Jun 25, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 138,800 | $0.33 | $45.8K Sale | Form 4 ↗ |
| Jun 24, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 231,600 | $0.35 | $81.1K Sale | Form 4 ↗ |
| Apr 24, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 68,195 | $0.32 | $21.8K Sale | Form 4 ↗ |
| Apr 23, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 89,328 | $0.34 | $30.4K Sale | Form 4 ↗ |
| Apr 22, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 78,049 | $0.34 | $26.5K Sale | Form 4 ↗ |
| Apr 17, 2025 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 77,090 | $0.33 | $25.4K Sale | Form 4 ↗ |
| Apr 16, 2025 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 61,638 | $0.33 | $20.3K Sale | Form 4 ↗ |
| Apr 15, 2025 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 10,326 | $0.38 | $3,924 Sale | Form 4 ↗ |
| Feb 11, 2025 | Kathleen Borthwick CFO | PASG Passage Bio, Inc. | Sale | 3,183 | $0.53 | $1,687 Sale | Form 4 ↗ |
| Jan 14, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 79,024 | $0.60 | $47.4K Sale | Form 4 ↗ |
| Jan 13, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 17,986 | $0.64 | $11.5K Sale | Form 4 ↗ |
| Jan 10, 2025 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 126,209 | $0.66 | $83.3K Sale | Form 4 ↗ |
| Jan 8, 2025 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 75,007 | $0.68 | $51.0K Sale | Form 4 ↗ |
| Jan 7, 2025 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 52,536 | $0.71 | $37.3K Sale | Form 4 ↗ |
| Jan 6, 2025 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 19,481 | $0.77 | $15.0K Sale | Form 4 ↗ |
| Dec 27, 2024 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 373,645 | $0.65 | $242.9K Buy | Form 4 ↗ |
| Dec 20, 2024 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 230,321 | $0.60 | $138.2K Sale | Form 4 ↗ |
| Dec 11, 2024 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 80 | $0.80 | $64 Sale | Form 4 ↗ |
| Dec 10, 2024 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 8,015 | $0.80 | $6,412 Sale | Form 4 ↗ |
| Dec 9, 2024 | Orbimed Advisors LLC 10% owner | PASG Passage Bio, Inc. | Sale | 54,181 | $0.84 | $45.5K Sale | Form 4 ↗ |
| Dec 6, 2024 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 20,903 | $0.82 | $17.1K Sale | Form 4 ↗ |
| Dec 4, 2024 | OrbiMed Capital GP VII LLC 10% owner | PASG Passage Bio, Inc. | Sale | 76,200 | $0.79 | $60.2K Sale | Form 4 ↗ |
| Nov 27, 2024 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 29,300 | $0.67 | $19.6K Buy | Form 4 ↗ |
| Nov 26, 2024 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 167,055 | $0.71 | $118.6K Buy | Form 4 ↗ |
| Nov 25, 2024 | Lynx1 Capital Management LP 10% owner | PASG Passage Bio, Inc. | Buy | 259,998 | $0.56 | $145.6K Buy | Form 4 ↗ |
35 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:05 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances